Company News
디엑스앤브이엑스, 사업개발·글로벌 딜 전문가 윤명진 전무 영입
2024.11.19
Company News
디엑스앤브이엑스 "'MEDICA 2024'서 유럽시장 판로 모색"
2024.11.18
Company News
디엑스앤브이엑스, mRNA 백신 한계 극복 기술 개발
2024.11.01
Company News
DXVX Develops Groundbreaking Technology to Overcome mRNA Vaccine Storage Limitations Verifies Possibility of Room-Temperature Storage for Over 10 Years Through Preliminary Research
2024.11.01
Company News
DX&VX Selected for Korea's First ARPA-H Project in 2024, Focusing on Room Temperature and Extra-Long-Term Vaccine Storage Technology
2024.11.01
Company News
Dx&Vx, ‘상온 초장기 비축 mRNA백신소재 및 대량생산 공정기술 개발’ 국책과제 선정
2024.10.30
Company News
Dx&Vx, 'Room temperature ultra-long-term stockpiling mRNA vaccine material and mass production process technology development' selected as national projec
2024.10.30
Company News
디엑스앤브이엑스, 영국 OVM 항암백신 도입 실사 완료
2024.10.28
Company News
디엑스앤브이엑스,'Medical Japan 2024 Tokyo'서 헬스케어 제품 소개
2024.10.28
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8.